Over-the-counter use of short-acting beta-2 agonists: a systematic review.
Zhe Chi LohRabia HussainSiew Chin OngBandana SainiJaya MuneswaraoAnees Ur-RehmanZaheer-Ud-Din BabarPublished in: Journal of pharmaceutical policy and practice (2023)
Over-the-counter purchase and overuse of SABA medication is a common problem, leading to adverse consequences such as uncontrolled asthma and increased healthcare utilization. Addressing these issues requires improved patient education about their conditions and adequate information regarding the potential long-term effects of SABA use by the healthcare providers. Management and education of asthma patients, including regular monitoring and follow-up, can help reduce overuse of SABA medication and prevent negative consequences.
Keyphrases
- healthcare
- end stage renal disease
- chronic obstructive pulmonary disease
- lung function
- chronic kidney disease
- ejection fraction
- adverse drug
- peritoneal dialysis
- quality improvement
- allergic rhinitis
- emergency department
- case report
- risk assessment
- patient reported outcomes
- health insurance
- social media
- human health